Tenax Therapeutics, Inc. (TENX)
Last updated: 2026-10-24 14:21:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Tenax Therapeutics, Inc. (TENX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.73, with a market capitalization of $65.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $19.40. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$65.87M | |
$1.76 | |
$152,320.00 | |
$1.31 | |
$1.76 | |
748.25K | |
5.75M | |
-- | |
$19.40 | |
$1.31 | |
-- | |
-- |
Tenax Therapeutics, Inc. (TENX) Latest Closing Stock Price
Tenax Therapeutics, Inc. (TENX) last closed at $1.76 as of 2026-10-23 23:58:00, unchanged from the previous close of $1.76.
During the latest regular trading session, TENX traded between $1.31 and $152,320.00, with a volume of 748.25K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Tenax Therapeutics, Inc. (TENX) 7-Day Stock Price Change
Over the past seven days, Tenax Therapeutics, Inc. (TENX) moved from $1.51 to $1.73, representing a gain of 14.24% ($0.22).
The stock traded between $1.36 and $1.84 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.06 million shares, down versus the previous seven-day period, indicating lower trading activity.
TENX 52-Week Price Position
Position in Range: 2.3%
TENX is currently trading at $1.73, placing it 2.3% of the way from its 52-week low of $1.31 to its 52-week high of $19.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Tenax Therapeutics, Inc. (TENX)?
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Tenax Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 16 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Tenax Therapeutics, Inc. (TENX) Stock on MEXC
Eligible investors can buy real shares of Tenax Therapeutics, Inc. (TENX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Tenax Therapeutics, Inc. (TENX) stock price today?
2.Is TENX stock going up or down today?
3.What is TENX pre-market price?
4.What is TENX after-hours price?
5.Is TENX stock trading now?
6.Where does TENX sit relative to its 52-week high and low?
7.What sector is Tenax Therapeutics, Inc. in?
8.What is Tenax Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is TENX valued in terms of P/E ratio and EPS?
10.Does Tenax Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
TENX Stock Calculator
Estimate the value between TENX shares and USD.
TENX Shares to USD
1.00 TENX shares = 1.725 USD
Calculations are estimates based on the latest available price and are for reference only.


